Certified by Founder Lodge
Wellington Management
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $238,000,000
68 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
-
Website
https://www.wellington.com/en/about-us/why-wellington-management
- Contact
- Social Links
For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best inv
| Company | Date | Round | Raised |
|---|---|---|---|
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 SeatGeek |
September, 01 ,2022 | Series E | $238,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
 FalconX |
June, 22 ,2022 | Series D | $150,000,000 |
 Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
 Arcadia |
May, 10 ,2022 | Series E | $200,000,000 |
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
 AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
 Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
 Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
dezerv.
Kristal.AI
Finary
Savart
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
